HG-02A PHASE 1/2 TRIAL OF THE ANTIBODY PIDILIZUMAB (MDV9300) IN PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA

Neuro-oncology(2016)

Cited 1|Views16
No score
Key words
antibody pidilizumab,pediatric diffuse intrinsic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined